The oversubscribed round was led by DigiTx Partners, with participation by Freeflow Ventures and other existing investors with extensive accomplishments across neuroradiology, stroke, and medical devices. David J. Kim, MD, Managing Director of DigiTx Partners, will be joining the board. To date, StrokeDx's technology has raised almost $10 million, including a National Institutes of Health (NIH) R01 Grant. This latest investment will support further clinical validation of StrokeDx's groundbreaking technology and the expansion of its commercial efforts.

StrokeDx is at the forefront of developing next-generation stroke detection technology. Our mission is to provide early, accurate, and accessible stroke monitoring and detection solutions to improve patient outcomes and reduce the global burden of stroke.